Stocks and InvestingStocks and Investing
Thu, April 1, 2021
Wed, March 31, 2021
Tue, March 30, 2021
Mon, March 29, 2021
Fri, March 26, 2021

Andrew Fein Maintained (ZNTL) at Strong Buy with Increased Target to $65 on, Mar 26th, 2021


Published on 2024-10-27 16:03:15 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy with Increased Target from $43 to $65 on, Mar 26th, 2021.

Andrew has made no other calls on ZNTL in the last 4 months.



There are 2 other peers that have a rating on ZNTL. Out of the 2 peers that are also analyzing ZNTL, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Robert Driscoll of "Wedbush" Initiated at Buy and Held Target at $65 on, Wednesday, January 20th, 2021
  • John Morrison of "Morgan Stanley" Maintained at Buy with Increased Target to $75 on, Wednesday, December 16th, 2020